| Glenmark Pharmaceuticals Ltd has informed BSE that at the meeting of the Operation Committee of Directors held on October 08, 2009, the Board has approved the conversion of 29200 stock options issued to its employees into 29200 Equity Shares pursuant to the ESOP 2003. |

